Document Type

Article

Publication Date

1-20-2022

Publication Title

NPJ Genom Med

Keywords

JGM

JAX Source

NPJ Genom Med 2022 Jan 20; 7(1):5

Volume

7

Issue

1

First Page

5

Last Page

5

ISSN

2056-7944

PMID

35058451

DOI

https://doi.org/10.1038/s41525-021-00276-8

Abstract

Consumer interest in genetic and genomic testing is growing rapidly, with more than 26 million Americans having purchased direct-to-consumer genetic testing services. Capitalizing on the increasing comfort of consumers with genetic testing outside the clinical environment, commercial vendors are expanding their customer base by marketing genetic and genomic testing services, including testing for pharmacogenomic and pathogenic variants, to employers for inclusion in workplace wellness programs. We describe the appeal of voluntary workplace genomic testing (wGT) to employers and employees, how the ethical, legal, and social implications literature has approached the issue of genetic testing in the workplace in the past, and outline the relevant legal landscape. Given that we are in the early stages of development of the wGT market, now is the time to identify the critical interests and concerns of employees and employers, so that governance can develop and evolve along with the wGT market, rather than behind it, and be based on data, rather than speculative hopes and fears.

Comments

This is an open access article distributed under the terms of the Creative Commons Attribution License.

Download

Share

COinS